April 2014

Features

New diagnostics may be a boon to both patient care and practice development.

A primer for ophthalmologists on starting a new pharmaceutical company and bringing a new drug to market.

It is our privilege as eye doctors to help enhance health, preserve sight … and provide insight.

Today’s advanced technology calls for a well-informed user in order to optimize results. Here’s help.

Surgeons detail the manual techniques that complement femtosecond laser surgery.

A look at recent attempts to replace postop eye drops with injections and the pros and cons of this approach.

National Quality Strategy Domains, Qualified Clinical Data Registry options and other changes you should know about.

How clinical electrophysiology can improve your diagnosis and management of posterior segment disease.

Despite the best intentions of the FDA, generic versions of drugs are not always identical to their branded counterparts.

Despite similarities to glaucoma in adults, the clinical findings and surgical management of pediatric glaucoma vastly differ.

How different drug formulations and dosing regimens may help ensure that patients take their medicine.

Making patients understand monovision and what to expect from it is half the battle, surgeons say.

A recent history of conjunctivitis and a worsening proptosis leads to a recommendation of a thyroid disease workup.